BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 19408054)

  • 1. Prophylactic total gastrectomy (PTG) for hereditary diffuse gastric cancer (HDGC): the Newfoundland experience with 23 patients.
    Hebbard PC; Macmillan A; Huntsman D; Kaurah P; Carneiro F; Wen X; Kwan A; Boone D; Bursey F; Green J; Fernandez B; Fontaine D; Wirtzfeld DA
    Ann Surg Oncol; 2009 Jul; 16(7):1890-5. PubMed ID: 19408054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laparoscopic Prophylactic Total Gastrectomy for Hereditary Diffuse Gastric Cancer in
    Ithurralde-Argerich J; Rosner L; Rizzolo M; Faerberg A; Puma R; Ferro D; Duque C; Kujaruk M; Cuenca-Abente F
    J Laparoendosc Adv Surg Tech A; 2021 Jul; 31(7):729-737. PubMed ID: 34097461
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic and prophylactic gastrectomy in a family with hereditary diffuse gastric cancer secondary to a CDH1 mutation: a case series.
    Gjyshi O; Vashi P; Seewald L; Kohan M; Abboud E; Fowler E; Suppiah R; Halabi H
    World J Surg Oncol; 2018 Jul; 16(1):143. PubMed ID: 30007404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDH1 and hereditary diffuse gastric cancer: a narrative review.
    Gregory SN; Davis JL
    Chin Clin Oncol; 2023 Jun; 12(3):25. PubMed ID: 37303221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathologic Analysis of Signet-ring Cell Carcinoma In Situ in Patients With Hereditary Diffuse Gastric Cancer.
    Tsugeno Y; Nakano K; Nakajima T; Namikawa K; Takamatsu M; Yamamoto N; Fujisaki J; Nunobe S; Kitagawa M; Takeuchi K; Kawachi H
    Am J Surg Pathol; 2020 Sep; 44(9):1204-1212. PubMed ID: 32520759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barriers and facilitators to CDH1 carriers contemplating or undergoing prophylactic total gastrectomy.
    McGarragle KM; Hart TL; Swallow C; Brar S; Govindarajan A; Cohen Z; Aronson M
    Fam Cancer; 2021 Apr; 20(2):157-169. PubMed ID: 32754788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of c.1531C>T Pathogenic Variant in the
    Norero E; Alarcon MA; Hakkaart C; de Mayo T; Mellado C; Garrido M; Aguayo G; Lagos M; Torres J; Calvo A; Guilford P; Corvalan AH
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31600923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic heterogeneity of hereditary diffuse gastric cancer: report of a family with early-onset disease.
    Gullo I; Devezas V; Baptista M; Garrido L; Castedo S; Morais R; Wen X; Rios E; Pinheiro J; Pinto-Ribeiro I; Ferreira RM; Preto J; Santos-Antunes J; Marques M; Campos M; Almeida F; Espinheira MDC; Amil Dias J; Figueiredo C; Oliveira C; Trindade E; Carneiro F
    Gastrointest Endosc; 2018 Jun; 87(6):1566-1575. PubMed ID: 29454568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study of total gastrectomy for CDH1-positive hereditary diffuse gastric cancer.
    Chen Y; Kingham K; Ford JM; Rosing J; Van Dam J; Jeffrey RB; Longacre TA; Chun N; Kurian A; Norton JA
    Ann Surg Oncol; 2011 Sep; 18(9):2594-8. PubMed ID: 21424370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary diffuse gastric cancer: surgery, surveillance and unanswered questions.
    Cisco RM; Norton JA
    Future Oncol; 2008 Aug; 4(4):553-9. PubMed ID: 18684065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laparoscopic prophylactic total gastrectomy with limited lymphadenectomy for CDH1 gene carriers.
    Bryant MK; Sillcox R; Grady WM; Oelschlager BK
    Surg Endosc; 2023 Dec; 37(12):9373-9380. PubMed ID: 37644154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer.
    Norton JA; Ham CM; Van Dam J; Jeffrey RB; Longacre TA; Huntsman DG; Chun N; Kurian AW; Ford JM
    Ann Surg; 2007 Jun; 245(6):873-9. PubMed ID: 17522512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is prophylactic gastrectomy indicated for healthy carriers of CDH1 gene mutations associated with hereditary diffuse gastric cancer?
    Munitiz Ruiz V; Jimeno P; Ruiz de Angulo D; Ortiz Á; Martínez de Haro LF; Marín M; Cascales P; Ruiz García G; Ortiz Ruiz E; Parrilla P
    Rev Esp Enferm Dig; 2019 Mar; 111(3):189-192. PubMed ID: 30466290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete histopathologic examination of risk reduction gastrectomy specimens for CDH1 germline mutation: Is it warranted in routine clinical practice?
    Zhang Q; Yang Z; Karamchandani DM
    Ann Diagn Pathol; 2020 Apr; 45():151473. PubMed ID: 31986421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of endoscopy in the management of hereditary diffuse gastric cancer syndrome.
    Kumar S; Long JM; Ginsberg GG; Katona BW
    World J Gastroenterol; 2019 Jun; 25(23):2878-2886. PubMed ID: 31249446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
    van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
    Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review of the indications for genetic testing and prophylactic gastrectomy among patients with hereditary diffuse gastric cancer.
    Seevaratnam R; Coburn N; Cardoso R; Dixon M; Bocicariu A; Helyer L
    Gastric Cancer; 2012 Sep; 15 Suppl 1():S153-63. PubMed ID: 22160243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes after prophylactic gastrectomy for hereditary diffuse gastric cancer.
    van der Kaaij RT; van Kessel JP; van Dieren JM; Snaebjornsson P; Balagué O; van Coevorden F; van der Kolk LE; Sikorska K; Cats A; van Sandick JW
    Br J Surg; 2018 Jan; 105(2):e176-e182. PubMed ID: 29341148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An investigation of the factors effecting high-risk individuals' decision-making about prophylactic total gastrectomy and surveillance for hereditary diffuse gastric cancer (HDGC).
    Hallowell N; Badger S; Richardson S; Caldas C; Hardwick RH; Fitzgerald RC; Lawton J
    Fam Cancer; 2016 Oct; 15(4):665-76. PubMed ID: 27256430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of Endoscopic Surveillance in Individuals With Genetic Predisposition to Hereditary Diffuse Gastric Cancer.
    Jacobs MF; Dust H; Koeppe E; Wong S; Mulholland M; Choi EY; Appelman H; Stoffel EM
    Gastroenterology; 2019 Jul; 157(1):87-96. PubMed ID: 30935944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.